Find trials
Search tips

A Study Of MR Sequences And Reconstruction Techniques For Neuroradiology Indications

Overview

About this study

The purpose of this study is to evaluate GE Healthcare advanced MR sequences and reconstruction techniques for their ability to decrease MR scan time and improve sensitivity for patients undergoing clinically-indicated neurological MR exams, including 1) Alzheimer’s Disease treatment monitoring, 2) diagnosis and monitoring of multiple sclerosis and 3) diagnosis and monitoring of epilepsy

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients undergoing MR neuro imaging, aged 18 and above.

 Exclusion Criteria:

  • <18yo, contraindication to 3T MR (device/implant). Pregnancy.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/31/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Steven Messina, M.D.

Contact us for the latest status

Contact information:

Steven Messina

messina.steven@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20598505

Mayo Clinic Footer